Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12,169
Closed -$273K 575
2019
Q3
$273K Sell
12,169
-199,883
-94% -$4.7M ﹤0.01% 436
2019
Q2
$4.71M Buy
212,052
+5,999
+3% +$129K 0.07% 54
2019
Q1
$4.41M Buy
206,053
+4,152
+2% +$92.2K 0.07% 57
2018
Q4
$4.37M Sell
201,901
-2,133
-1% -$51.6K 0.09% 53
2018
Q3
$5.32M Sell
204,034
-14
-0% -$359 0.1% 51
2018
Q2
$5.03M Buy
204,048
+1,297
+0.6% +$30.1K 0.1% 53
2018
Q1
$4.35M Buy
202,751
+15,909
+9% +$341K 0.09% 59
2017
Q4
$3.83M Sell
186,842
-14,677
-7% -$281K 0.08% 62
2017
Q3
$3.65M Buy
+201,519
New +$3.91M 0.08% 63

Other funds holding SABR

Greenleaf Trust's SABR Position: Q4 2019 in Review

Greenleaf Trust sold out of Sabre (SABR) in Q4 2019, closing a stake of 12,169 shares — an estimated $273K sold.

Greenleaf Trust first reported a position in SABR in Q3 2017 and held it in 9 quarters. The position peaked at $5.32M in Q3 2018. 348 funds tracked by Wall St. Rank hold SABR as of Q4 2019.

  • Greenleaf Trust reported no remaining Sabre position as of Q4 2019 after selling out during the quarter.
  • Greenleaf Trust sold 12,169 Sabre shares in Q4 2019, an estimated $273K.
  • Greenleaf Trust first reported a position in Sabre in Q3 2017 and held it in 9 quarters.
  • Greenleaf Trust's Sabre position peaked at $5.32M in Q3 2018.
  • 348 funds tracked by Wall St. Rank held Sabre as of Q4 2019.

Based on Greenleaf Trust's 13F filing for Q4 2019, filed 11 Feb 2020.